The global ventricular hypertrophy treatment market is projected to experience significant growth in the coming years. This development can be attributed to a mixture of factors, including an increasing elderly demographic, rising prevalence of cardiovascular diseases, and advancements in therapies available. The is propelled by a need for effecti